This clinical-stage biotech focused on precision medicines reported significant insider selling, according to recent SEC filings.
Known for its AI-driven data solutions, this tech firm reported significant insider selling amid ongoing digital transformation initiatives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback